HOME >> MEDICINE >> NEWS
Pfizer's VFEND(R) receives FDA approval for treatment of esophageal candidiasis

NEW YORK, November 17, 2003 - Pfizer Inc said today that it has received U.S. Food and Drug Administration (FDA) approval to market VFEND (voriconazole), a broad spectrum antifungal medicine, for the treatment of esophageal candidiasis.

Candida organisms are normally found on skin and mucous membranes in healthy individuals, but in persons whose immune systems are weakened or compromised by cancer chemotherapy, organ transplants or HIV/AIDS, Candida can multiply causing potentially serious infections. In immunocompromised patients, esophageal candidiasis may coat much of the surface of the mouth resulting in pain and difficulty swallowing and may ultimately progress to more serious, invasive disease.

The basis for the approval of VFEND to treat esophageal candidiasis infections was a clinical trial with immunocompromised patients conducted at study sites in 15 countries. All patients had a proven diagnosis of esophageal candidiasis and most of the patients also had additional underlying diseases, such as hematologic malignancies, chronic obstructive pulmonary disease (COPD) and AIDS.

Patients received either VFEND or fluconazole. Those treated with VFEND had success rates of 98 percent compared to 95 percent for fluconazole. Both VFEND and fluconazole had acceptable tolerability and safety. VFEND was discovered by Pfizer researchers and was developed to address the unmet medical need for more effective and better-tolerated options for patients with invasive aspergillosis and other serious fungal infections.

Initially, VFEND was approved in the U.S. for the primary treatment of acute invasive aspergillosis and salvage therapy for rare but serious fungal infections caused by the pathogens Scedosporium apiospermum and Fusarium spp. VFEND can be administered both orally and intravenously. Pfizer is continuing to study VFEND for the treatment of serious fungal infections.

In clinical trials, the most common adverse
'"/>

Contact: Susan Yarin
susan.yarin@pfizer.com
212-733-5260
Edelman Public Relations
17-Nov-2003


Page: 1 2

Related medicine news :

1. FDA approves Pfizers Lyrica for the treatment of the two most common forms of neuropathic pain
2. Pfizers antifungal medicine VFEND receives FDA approval
3. New data sets survival benchmark for Pfizers ELLENCE
4. Pfizers VFEND (R) as effective in treating Candidemia as two-drug standard of care, study shows
5. Pfizers ZYVOX(TM) more effective than vancomycin in treating complicated SSTIs caused by MRSA
6. UIC professor receives international humanitarian award
7. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
8. Epidemiologist Trichopoulos receives $5.8 million Department of Defense Innovator Award
9. GlaxoSmithKline receives unanimous favorable recommendation by FDA Advisory Committee for Boostrix
10. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
11. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2020)... ... May 26, 2020 , ... ... leading RevSpring solutions—Talksoft® patient messaging and IVR Advantage™--for Loyale customers. Talksoft pre-service ... automated and precise texts, IVR reminders and email messages tailored to each ...
(Date:5/26/2020)... ... May 26, 2020 , ... Sex educator, activist, humanitarian, and Wicked Pictures ... have just received the 2020 AASECT Audio Visual Award for jessica drake's Guide to ... of its kind to feature non-actors in its demonstrations and narratives and was produced ...
(Date:5/25/2020)... ... May 23, 2020 , ... Winemaker Grant Long Jr. ... wanted to present something whimsical and delicious in these complicated times,” he said, in ... ($34.99) and 2018 Grenache ($24.99). The Chardonnay and Red Wine Blend are sourced in ...
(Date:5/21/2020)... ... 21, 2020 , ... In response to the Coronavirus pandemic, Industrial Magnetics, Inc.(IMI) ... open swing-style doors without using their hands or fingertips. , The new ... using their forearm, wrist or elbow when entering or exiting a room. , Perfect ...
(Date:5/21/2020)... Pa. (PRWEB) , ... May 21, 2020 , ... ... Inc. and an industry leader in cancer biomarker assays, announced today that Cigna ... list. Cigna Corporation is a global health service company dedicated to improving the ...
Breaking Medicine News(10 mins):
(Date:5/27/2020)... ... ... Dr. Anuj Shah , CHIROPRACTIC CARE, Bergen County, ... , Morris County, Dr. Derek Ferguson , ... County, Dr. Krista King , Union County, ...
(Date:5/27/2020)... ... ... Giving Away Free CBD Supplements for the next 60 days , Hemp Health One is ... daily giveaway contest on its Instagram and Facebook pages. , The rules to ... Facebook page. Then, like the most recent post, share it, or tag a friend. The ...
(Date:5/26/2020)... , ... May 26, 2020 , ... Melwood is proud ... abilities to DC area hospitals, food pantries, group homes and nursing homes. “It’s more ... healthcare workers on the front lines and bring a little cheer to seniors and ...
Breaking Medicine Technology:
Cached News: